Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple primary lung cancers

A F Verhagen1, G Tavilla, H J van de Wal

  • 1Department of Thoracic and Cardiac Surgery, University Hospital St. Radboud, Nijmegen, The Netherlands.

The Thoracic and Cardiovascular Surgeon
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections.

Genes and immunity·2017
Same author

Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC<sup>3</sup> Study.

Journal of viral hepatitis·2016
Same author

Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents.

Journal of viral hepatitis·2016
Same author

Infectious canine hepatitis in red foxes (Vulpes vulpes) in wildlife rescue centres in the UK.

The Veterinary record·2016
Same author

Multicentre randomized clinical trial to investigate the cost-effectiveness of an allogeneic single-donor fibrin sealant after coronary artery bypass grafting (FIBER Study).

The British journal of surgery·2015
Same author

Identification of the 1B vaccine strain of Chlamydia abortus in aborted placentas during the investigation of toxaemic and systemic disease in sheep.

New Zealand veterinary journal·2015

A small percentage of lung cancer patients develop a second primary lung cancer. Survival rates are better for those with different histology, longer intervals between cancers, bilateral tumors, or early-stage second cancers.

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology
  • Pulmonary Medicine

Background:

  • Second primary lung cancers are a clinical challenge.
  • Understanding the characteristics and outcomes of these cancers is crucial for patient management.

Purpose of the Study:

  • To analyze the incidence, treatment, and survival outcomes of patients with synchronous and metachronous primary lung cancers.

Main Methods:

  • Retrospective review of 1287 lung cancer resections between 1970 and 1990.
  • Identification of 55 cases (4.3%) with a second primary lung cancer.
  • Analysis of synchronous (n=15) and metachronous (n=40) cases, including treatment modalities and survival data.

Main Results:

  • Synchronous cancers had a 3- and 5-year survival of 26% and 15%, respectively. Metachronous cancers had a 3- and 5-year survival of 33% and 18%.

Related Experiment Videos

  • Factors positively affecting survival included differing histology, longer intervals (>3 years), bilateral localization, and early-stage (I or II) second cancers.
  • Stage III second cancers had a poor prognosis, with all patients dying within 14 months.

    • Conclusions:

    • Second primary lung cancers represent a significant subset of lung cancer cases.
    • Surgical management and patient-specific factors like tumor stage and histology influence survival outcomes.
    • Early detection and tailored treatment strategies are essential for improving prognosis in patients with multiple primary lung cancers.